VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2022 | The DUSP6-RSK1 pathway: a driver of disease progression in MPNs

Stephen Oh, MD, PhD, Washington University School of Medicine, St. Louis, MO, discusses the promise of targeting the DUSP6-RSK1 pathway in myeloproliferative neoplasms (MPNs), which has shown to be a driver of disease progression. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter